TT-00420 (Tinengotinib)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for TT-00420 (Tinengotinib), covering 2025-08-21 to 2025-08-21. Get the full timeline:
Most recent: Clinical Trial Update: Study of TT-00420 (Tinengotinib) in Subjects With Cholangiocarcinoma Who Failed or Relapsed to Chemotherapy and FGFR Inhibitor [Phase 2]